Paper28106295
Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer.
Tariq M and 5 others. J Cell Biochem, 2017. Cited by 146 papers, by iCite.
Cite this record
ConductScience Library. Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer. Papers, record 28106295. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28106295
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Drug Delivery Systems | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Macrophages | Major topic |
| Neovascularization, Pathologic | Major topic |
| Tumor Microenvironment | Major topic |
| Animals | |
| Extracellular Matrix | |
| Female | |
| Humans | |
| Neoplasm Metastasis |
Source PubMed
Cited by108
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41922320 | MLK4 orchestrates macrophage-induced triple-negative breast cancer invasion and ECM remodeling via enhanced paracrine signaling and NF-κB-MMP axis activation. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41922320 | PubMed |
| 41439136 | Ferroptosis: The dawn of reversing drug resistance in digestive cancers. | Genes Dis | 2026 | https://conductscience.org/library/papers/41439136 | PubMed |
| 41097709 | Macrophages-Target and Tool in Tumor Treatment: Insights from Ovarian Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41097709 | PubMed |
| 40688034 | CaF2 nanoparticles deliver siRNA targeting STAT6 and PPAR- γ to depolarise tumour-associated macrophages. | BBA Adv | 2025 | https://conductscience.org/library/papers/40688034 | PubMed |
| 40649751 | Tumor-Associated Macrophage in Breast Tumor Microenvironment. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40649751 | PubMed |
| 40553285 | In Vitro Models to Compare the Duration of Action of New Therapeutic Scaffolds and Drug Eluting Medical Devices. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/40553285 | PubMed |
| 40510374 | ReSort enhances reference-based cell type deconvolution for spatial transcriptomics through regional information integration. | Bioinform Adv | 2025 | https://conductscience.org/library/papers/40510374 | PubMed |
| 40297497 | Research progress on the impact of opioids on the tumor immune microenvironment (Review). | Mol Clin Oncol | 2025 | https://conductscience.org/library/papers/40297497 | PubMed |
| 40232576 | Predicting survival and immune status of breast cancer patients based on prognostic features related to PANoptosis. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40232576 | PubMed |
| 40048034 | Macrophage-derived lncRNAs in cancer: regulators of tumor progression and therapeutic targets. | Med Oncol | 2025 | https://conductscience.org/library/papers/40048034 | PubMed |
| 40008212 | Tumor Microenvironment Modulation by Tumor-Associated Macrophages: Implications for Neoadjuvant Chemotherapy Response in Breast Cancer. | Breast Cancer (Dove Med Press) | 2025 | https://conductscience.org/library/papers/40008212 | PubMed |
| 39470328 | The influence of biophysical niche on tumor-associated macrophages in liver cancer. | Hepatol Commun | 2024 | https://conductscience.org/library/papers/39470328 | PubMed |
| 39403485 | Single-cell analysis reveals T cell dysfunction driven by macrophages and differential expression of transposable elements in severe COVID-19 patients. | Heliyon | 2024 | https://conductscience.org/library/papers/39403485 | PubMed |
| 39227722 | Identification of lysine lactylation (kla)-related lncRNA signatures using XGBoost to predict prognosis and immune microenvironment in breast cancer patients. | Sci Rep | 2024 | https://conductscience.org/library/papers/39227722 | PubMed |
| 39219410 | Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative review. | Animal Model Exp Med | 2024 | https://conductscience.org/library/papers/39219410 | PubMed |
| 39150566 | Advances in manufacturing chimeric antigen receptor immune cell therapies. | Semin Immunopathol | 2024 | https://conductscience.org/library/papers/39150566 | PubMed |
| 39005910 | The role of CD8+ T-cells in colorectal cancer immunotherapy. | Heliyon | 2024 | https://conductscience.org/library/papers/39005910 | PubMed |
| 38591208 | An Epic Advancement in Targeting Macrophages for Cancer Therapy Approach. | Curr Drug Deliv | 2025 | https://conductscience.org/library/papers/38591208 | PubMed |
| 38340231 | Protocols for Co-Culture Phenotypic Assays with Breast Cancer Cells and THP-1-Derived Macrophages. | J Mammary Gland Biol Neoplasia | 2024 | https://conductscience.org/library/papers/38340231 | PubMed |
| 38289597 | Identification of gut microbes-related molecular subtypes and their biomarkers in colorectal cancer. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/38289597 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28106295
GET https://conductscience.org/api/papers/v1/28106295/cited_by?page=2